propafenone hydrochloride
Generic: propafenone hydrochloride
Labeler: upsher-smith laboratories, llcDrug Facts
Product Profile
Brand Name
propafenone hydrochloride
Generic Name
propafenone hydrochloride
Labeler
upsher-smith laboratories, llc
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
propafenone hydrochloride 225 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0832-0740
Product ID
0832-0740_45afbac0-5c1a-ebc5-e063-6294a90a4d5e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212744
Marketing Start
2020-06-25
Marketing End
2026-11-30
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
08320740
Hyphenated Format
0832-0740
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
propafenone hydrochloride (source: ndc)
Generic Name
propafenone hydrochloride (source: ndc)
Application Number
ANDA212744 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 225 mg/1
Packaging
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0740-60)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45afbac0-5c1a-ebc5-e063-6294a90a4d5e", "openfda": {"upc": ["0308320740607"], "unii": ["33XCH0HOCD"], "rxcui": ["861156", "861164", "861171"], "spl_set_id": ["8aa6f58a-2980-4caa-9c54-d55d69d5d132"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0740-60)", "package_ndc": "0832-0740-60", "marketing_end_date": "20261031", "marketing_start_date": "20200625"}], "brand_name": "Propafenone Hydrochloride", "product_id": "0832-0740_45afbac0-5c1a-ebc5-e063-6294a90a4d5e", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Antiarrhythmic [EPC]"], "product_ndc": "0832-0740", "generic_name": "Propafenone Hydrochloride", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Propafenone Hydrochloride", "active_ingredients": [{"name": "PROPAFENONE HYDROCHLORIDE", "strength": "225 mg/1"}], "application_number": "ANDA212744", "marketing_category": "ANDA", "marketing_end_date": "20261130", "marketing_start_date": "20200625"}